Jobst Technologies published in the Meditronic Journal – Technical Journal for Medical Engineering (Page 51)
Only available in German
Jobst Technologies presents at Medtec Live, 21-23 May 2019, Nürnberg, Hall 10.0 / 10.0-535
Jobst Technologies as the emerging player in component supplier for the perfusion system.
Details here https://lnkd.in/eH79UnJ
Gerhard Jobst, CEO of Jobst Technologies, will give the keynote talk
An autosampling micro-analyzer. Functions, performance, and prospects (L43)
Session 5B: Microsensors for bioprocesses
Wednesday, March 21, 2018, 14:55
Jobst Technologies got granted the new project “Microfluidic Lab-on-a-Bird transmitter for the hormone level monitoring of free-moving birds”.
Subject of the project with €1.52 million funding from Max Planck Society Munich, is an autonomous miniaturized laboratory for collecting blood, measuring the level of stress hormones and sending the signal from the free moving bird to the “ground station”.
Jobst Technologies GmbH will develop the automated blood- sampling- and microfluidic- system enabling integration and operation of the assay. Jobst Technologies’ micropumps and flow rate sensor will also be used as enabling components.
Project partners are the Max Planck Institute for Ornithology and the Albert-Ludwigs-University Freiburg.
Jobst Technologies got granted the new H2020 Key Enabling Technologies project 737212 – CATCH-U-DNA.
Seven partners aim to enable analysis for free circulating tumor DNA – a major brick in individualized cancer treatment. This project will strengthen Jobst’s vanguard position in performance micro-fluidics and extreme bio-sensing.